Currently predicting for Thu, 4 Jun 2026

HROW Prediction Chart

HROW Predictions History

Latest community submissions for HROW.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 17, 2025 $39.79 -2.45% $40.29 V 98.76% 2
Nov 17, 2025 $40.16 -1.53% $40.29 V 99.69% 5
Nov 17, 2025 Bullish $40.29 V 0
May 30, 2023 $20.80 +3.41% $19.16 X 91.46% 0
May 30, 2023 $20.54 +2.13% $19.16 X 92.80% 0
Skagitqg Skagitqg Merchant
May 30, 2023 Bullish $19.16 X 0
JS JS Pro
Dec 7, 2021 $9.21 -4.06% $9.60 X 95.94% 0
Ti Li Ti Li @TiLi.161916
Dec 7, 2021 $9.47 -1.35% $9.60 X 98.65% 2
JS JS Pro
Jul 20, 2021 $7.29 -0.14% $7.30 X 99.86% 6
Reuven Zecharia Reuven Zecharia @ReuvenZecharia.160880
Jul 20, 2021 $7.44 +1.92% $7.30 X 98.08% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for HROW with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT IMPRIMIS PHARMACEUTICALS
Imprimis Pharmaceuticals
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharma...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE